Next-generation Sequencing of Cerebrospinal Fluid for the Diagnosis of Neurocysticercosis
Xiaofei Fei,Chaoyang Li,Yun Zhang,Hongya Zhang,Xuewu Liu,Xinchao Ji,Yajun Shi,Na Liu,Mengli Wu,Fang Du,Yining Yang,Wen Dai,TingTing Liu,Ying He,Ting Bian,Huimin Zhou,Xingyue An,Zheng Cai,Jian Shi,Guodong Feng,Ming Shi,Gang Zhao
DOI: https://doi.org/10.1016/j.clineuro.2020.105752
IF: 1.885
2020-01-01
Clinical Neurology and Neurosurgery
Abstract:Objective: Neurocysticercosis (NCC) is the most common parasitic disease of the human central nervous system (CNS). However, a diagnosis of NCC may be hard to make if the specific clinical and routine neuroimaging manifestations are lacking, which hinders physicians from considering further immunodiagnostic tests. Patients and methods: Seven patients presented with fever, headache, nausea, cognitive decline, confusion, or progressive leg weakness. There were no pathogens found in the cerebrospinal fluid (CSF); patients were clinically suspected of meningoencephalitis or cerebrovascular disease. To clearly determine the etiology, next generation sequencing (NGS) of the CSF was used to detect pathogens in these seven patients. Results: Taenia solium DNA sequences were detected in the seven patients, but not in the non-template controls (NTCs) or the other patients with clinically suspected CNS infections. Based on the patients' medical data and the diagnostic criteria for NCC, seven patients were diagnosed with probable NCC. The unique reads aligning to Taenia solium ranged from 6 to 261064, with genomic coverage ranging from 0.0003% to 14.8079%. The number of unique reads and genomic coverage dropped in three of the seven patients after antiparasitic treatment, consistent with the relief of symptoms. Conclusion: This study showed that NGS of the CSF might be an auxiliary diagnostic method for NCC patients. Larger studies are required.